Green Valley Drugs Recalls Testosterone Injections Due to Sterility Concerns
Green Valley Drugs is recalling 51 vials of Testosterone Cypionate and Testosterone Propionate Injection due to lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance for injectable drugs, which poses a significant risk of serious injury or death from infection.
Plain-English summary
FVS Holdings, Inc. dba. Green Valley Drugs is recalling 51 vials of Testosterone Cypionate and Testosterone Propionate Injection. The recall covers all strengths and presentations, including Testosterone cyp 200/test prop 20 mg 10 mL and Testosterone Cyp 200 mg/Test Prop 50 mg 10 mL. The products were distributed nationwide.
The recall was initiated due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. This action addresses concerns associated with the facility's quality control processes.
Consumers should stop using the affected products and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Testosterone Cypionate and Testosterone Propionate Injection, all strengths and all presentations including a) Testosterone cyp 200/test prop 20 mg 10 mL and b) Testosterone Cyp 200 mg/Test Prop 50 mg 10mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV…
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Category
- Drug — Injectable Steroids
- Affected units
- 51
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: a) Testosterone cyp 200/test prop 20 mg 10 mL: 130102500AE
- Exp 4/25/2013
- b) Testosterone Cyp 200 mg/Test Prop 50 mg 10 mL: 20130305-1
- Exp 6/5/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Cypionate/Propionate Injection Recalled for Sterility Assurance
FDA (Drugs) · 2021-10-06
- SevereIsomeric Pharmacy Recalls Testosterone Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2017-05-03
- High
- SevereNew Vitalis Pharmacy Recalls Testosterone Injection Due to Sterility Concerns
FDA (Drugs) · 2019-12-04
- SevereTestosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTestosterone Cypionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23